Folgen
Peter Openshaw
Peter Openshaw
Professor of Experimental Medicine
Bestätigte E-Mail-Adresse bei imperial.ac.uk - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
AB Docherty, EM Harrison, CA Green, HE Hardwick, R Pius, L Norman, ...
bmj 369, 2020
31022020
Genetic mechanisms of critical illness in COVID-19
E Pairo-Castineira, S Clohisey, L Klaric, AD Bretherick, K Rawlik, D Pasko, ...
Nature 591 (7848), 92-98, 2021
11522021
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ...
Nature immunology 21 (11), 1336-1345, 2020
10902020
Respiratory syncytial virus
A Jha, H Jarvis, C Fraser, P Openshaw
SARS, MERS and other viral lung infections, 2016
10212016
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
SR Knight, A Ho, R Pius, I Buchan, G Carson, TM Drake, J Dunning, ...
bmj 370, 2020
8812020
IFITM3 restricts the morbidity and mortality associated with influenza
AR Everitt, S Clare, T Pertel, SP John, RS Wash, SE Smith, CR Chin, ...
Nature 484 (7395), 519-523, 2012
7982012
SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ...
Cell 185 (3), 467-484. e15, 2022
7122022
Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations.
P Openshaw, EE Murphy, NA Hosken, V Maino, K Davis, K Murphy, ...
The Journal of experimental medicine 182 (5), 1357-1367, 1995
6731995
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
OV Swann, KA Holden, L Turtle, L Pollock, CJ Fairfield, TM Drake, S Seth, ...
bmj 370, 2020
6462020
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
6042021
Bronchiolitis
RL Smyth, PJM Openshaw
The lancet 368 (9532), 312-322, 2006
5932006
Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.
MJ Cannon, PJ Openshaw, BA Askonas
The Journal of experimental medicine 168 (3), 1163-1168, 1988
5531988
Reversibility of T helper 1 and 2 populations is lost after long-term stimulation.
E Murphy, K Shibuya, N Hosken, P Openshaw, V Maino, K Davis, ...
The Journal of experimental medicine 183 (3), 901-913, 1996
5391996
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ...
Cell 184 (5), 1171-1187. e20, 2021
5252021
Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
AB Docherty, EM Harrison, CA Green, H Hardwick, R Pius, L Norman, ...
MedRxiv, 2020.04. 23.20076042, 2020
4362020
Tracheostomy in the COVID-19 era: global and multidisciplinary guidance
BA McGrath, MJ Brenner, SJ Warrillow, V Pandian, A Arora, TS Cameron, ...
The Lancet Respiratory Medicine 8 (7), 717-725, 2020
4242020
Immune responses and disease enhancement during respiratory syncytial virus infection
PJM Openshaw, JS Tregoning
Clinical microbiology reviews 18 (3), 541-555, 2005
4172005
Distinct types of lung disease caused by functional subsets of antiviral T cells.
WH Alwan, WJ Kozlowska, PJ Openshaw
The Journal of experimental medicine 179 (1), 81-89, 1994
4011994
Inhibition of tumor necrosis factor reduces the severity of virus‐specific lung immunopathology
T Hussell, A Pennycook, PJM Openshaw
European journal of immunology 31 (9), 2566-2573, 2001
3802001
The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates
NI Mazur, D Higgins, MC Nunes, JA Melero, AC Langedijk, N Horsley, ...
The Lancet Infectious Diseases 18 (10), e295-e311, 2018
3682018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20